Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  BOIRON    BOI   FR0000061129

BOIRON

(BOI)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Paris
11/12/2019 11/13/2019 11/14/2019 11/15/2019 11/18/2019 Date
32.7(c) 32.35(c) 32.25(c) 32.3(c) 32.05 Last
3 036 1 930 6 630 7 149 2 661 Volume
-0.76% -1.07% -0.31% +0.16% -0.77% Change
More quotes
Financials (EUR)
Sales 2019 558 M
EBIT 2019 53,0 M
Net income 2019 31,9 M
Finance 2019 209 M
Yield 2019 2,43%
Sales 2020 538 M
EBIT 2020 50,8 M
Net income 2020 35,0 M
Finance 2020 217 M
Yield 2020 2,45%
P/E ratio 2019 17,8x
P/E ratio 2020 16,2x
EV / Sales2019 0,64x
EV / Sales2020 0,65x
Capitalization 566 M
More Financials
Company
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both... 
More about the company
Surperformance© ratings of BOIRON
Trading Rating : Investor Rating :
More Ratings
Latest news on BOIRON
10/24BOIRON : Activity in the third quarter of 2019
AN
10/24BOIRON : 3rd quarter earnings
CO
10/23JOINT PRESS RELEASE : Boiron and Lehning laboratories have filed two appeals aga..
PU
10/18BOIRON : Projected timetable of the next publications and events 2020
PU
10/18BOIRON : Provisional calendar
CO
10/09PRESS RELEASE : Australian authorities report recognizes « encouraging evidence ..
PU
10/09BOIRON : Australian authorities report recognizes " encouraging evidence " of ho..
AN
09/04BOIRON : 2019 half-year results
AN
09/04BOIRON : Half-year results
CO
07/18BOIRON : 2019 half-year activity
PU
07/18BOIRON : 2019 half-year activity
AN
07/10BOIRON : Arbitration of the Government on the reimbursement of homeopathic medic..
AN
06/30BOIRON : Half-year report
CO
06/28BOIRON : Press release of June 28,2019
PU
06/28BOIRON : Press release of June 28, 2019
AN
More news
News in other languages on BOIRON
10/24BOIRON : le CA du T3 en baisse de -8,2%
10/24BOIRON : Activité du troisième trimestre 2019
10/23BOIRON : Boiron and Lehning laboratories have filed two appeals against the decr..
10/23COMMUNIQUÉ DE PRESSE COMMUN : Les laboratoires Boiron et Lehning ont déposé deux..
10/23BOIRON : dépôt d'un recours devant le Conseil d'Etat
More news
Analyst Recommendations on BOIRON
More recommendations
Sector news : Alternative Medicine
10:36aDAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
10:18aA lot happening on the M&A side
09:55aNOVARTIS : switches gears in Shanghai from research to drug development
RE
09:34aALLERGAN : Form 8.3 -
DJ
09:32aAMGEN : Cytokinetics, Servier Unveil New Results from Omecamtiv Mecarbil Study
DJ
More sector news : Alternative Medicine
Chart BOIRON
Duration : Period :
BOIRON Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BOIRON
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus SELL
Number of Analysts 4
Average target price 30,00  €
Last Close Price 32,30  €
Spread / Highest target -2,48%
Spread / Average Target -7,12%
Spread / Lowest Target -13,3%
EPS Revisions
Managers
NameTitle
Valérie Poinsot Chief Executive Officer & Director
Thierry Boiron Chairman
Veronique Bouscayrol Chief Financial Officer
Christian Boiron Director
Jacky Abécassis Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
BOIRON-34.01%625
CANOPY GROWTH CORPORATION-44.58%5 347
BEIJING TONGRENTANG CO., LTD-3.82%5 176
DONG-E-E-JIAO CO LTD--.--%3 249
HUTCHISON CHINA MEDITECH LIMITED0.00%3 092
AURORA CANNABIS INC.-47.05%2 851